Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 7/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14456397 | 1.00 | EPHX1 (0.48) | EPHX1ALDH1A1DPP4NPC1RAB9A | |
| SCHEMBL21269514 | 0.97 | EPHX1 (0.46) | EPHX1ALDH1A1DPP4NPC1RAB9A | |
| SCHEMBL21269290 | 0.97 | EPHX1 (0.46) | EPHX1ALDH1A1DPP4NPC1RAB9A | |
| SCHEMBL21269065 | 0.97 | EPHX1 (0.46) | EPHX1ALDH1A1DPP4NPC1RAB9A | |
| SCHEMBL4611368 | 0.97 | EPHX1 (0.44) | EPHX1ALDH1A1DPP4NPC1RAB9A | |
| Ethane SCHEMBL7896237 | 0.95 | EPHX1 (0.44) | EPHX1ALDH1A1DPP4NPC1RAB9A | |
| SCHEMBL28727392 | 0.95 | EPHX1 (0.44) | EPHX1ALDH1A1DPP4NPC1RAB9A | |
| Benzene SCHEMBL7894864 | 0.95 | EPHX1 (0.44) | EPHX1ALDH1A1DPP4RAB9ASMN1; SMN2 | |
| Potassium SCHEMBL29456083 | 0.95 | EPHX1 (0.44) | EPHX1ALDH1A1DPP4NPC1RAB9A | |
| SCHEMBL4233684 | 0.92 | EPHX1 (0.39) | EPHX1ALDH1A1DPP4SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6409949-B1 | FEED RESIN CONTAINING CHAIN EXTENSION AGENT IS SUBJECTED TO MIXING WHILE BEING DEAERATED UNDER REDUCED PRESSURE IN SINGLE THICKENING CHAMBER | KABUSHIKI KAISHA KOBE SEIKO SHO (KOBE STEEL, LTD.) (JP) | 2002-06-25 | — | — | US | claimed |
| CN-119065043-A | Composition, optical film, layer, optical filter, optical element, solid-state imaging device, and camera module | JSR株式会社 | 2024-12-03 | — | — | CN | disclosed |
| US-20240368096-A1 | Fused Heterobicyclic Antiviral Agents | ENANTA PHARMACEUTICALS, INC. | 2024-11-07 | — | — | US | disclosed |
| US-20240140922-A1 | FUSED HETEROBICYCLIC ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. | 2024-05-02 | — | — | US | disclosed |
| WO-2024044183-A1 | FUSED HETEROBICYCLIC ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. (US) | 2024-02-29 | — | — | WO | disclosed |
| EP-4304842-A1 | METHOD FOR MAKING PHOTOFUNCTIONAL CONTACT LENSES | Alcon Inc. (CH) | 2024-01-17 | — | — | EP | disclosed |
| WO-2023116774-A1 | COMPOUND CONTAINING BIS(AZANYLYLIDENE) SULFONYL STRUCTURE AND USE THEREOF IN MEDICINE | 赛诺哈勃药业（成都）有限公司 | 2023-06-29 | — | — | WO | disclosed |
| EP-4158392-A1 | METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES | Alcon Inc. (CH) | 2023-04-05 | — | — | EP | disclosed |
| CN-111849509-B | Compound light stabilizer, and preparation method and application thereof | 北京八亿时空液晶科技股份有限公司 | 2023-01-06 | — | — | CN | disclosed |
| WO-2022189940-A1 | METHOD FOR MAKING PHOTOFUNCTIONAL CONTACT LENSES | ALCON INC. (CH) | 2022-09-15 | — | — | WO | disclosed |
| US-4694061-A | POLYAMIDE(IMIDE)S CONTAINING BENZOPHENONE (DI-ORTRI)CARBOXYLIC ACID | CIBA-GEIGY CORPORATION (US) | 1987-09-15 | — | — | US | disclosed |
| US-4612344-A | Flame-proofed, reinforced thermoplastic polyester moulding composition containing xonotlite | CIBA-GEIGY CORPORATION (US) | 1986-09-16 | — | — | US | disclosed |
| US-4568720-A | WITH PHOSPHITE COMPOUND | ALLIED CHEMICAL CORPORATION (US) | 1986-02-04 | — | — | US | disclosed |
| US-4417031-A | HEATING POLYMER MIXTURE IN PRESENCE OF PHOSPHITE COMPOUND | ALLIED CORPORATION (US) | 1983-11-22 | — | — | US | disclosed |
| US-4401784-A | ADDING DOLOMITE TO INCREASE STIFFNESS AND DIMENSIONAL STABILITY UNDER HEAT | CIBA-GEIGY CORPORATION (US) | 1983-08-30 | — | — | US | disclosed |
| EP-0084643-A1 | A process for preparing graft and block copolymers | ALLIED CORPORATION (US) | 1983-08-03 | — | — | EP | disclosed |
| US-4336343-A | CONTAINING SODIUM CITRATE | MORRIS TOWNSHIP, MORRIS COUNTY (US) | 1982-06-22 | — | — | US | disclosed |
| US-4156774-A | TEREPHTHALIC ACID, ETHYLENE GLYCOL, DIETHYLENE GLYCOL, BUTYLENE GLYCOL; HOT MELT ADHESIVES | CIBA-GEIGY CORPORATION (US) | 1979-05-29 | — | — | US | disclosed |
| US-4148956-A | TOUGH POLYESTERS WITH ACRYLONITRILE-STYRENE, MODIFIED WITH ACRYLATE, COPOLYMER | ALKOR GMBH (DE) | 1979-04-10 | — | — | US | disclosed |
| US-4108841-A | FROM DIACIDS CONTAINING HETEROCYCLIC RINGS | CIBA-GEIGY CORPORATION (US) | 1978-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368096-A1 | Fused Heterobicyclic Antiviral Agents | HAVCR2, HDGF, SLC10A1 | EPHX1 2362/4885ALDH1A1 3610/4885DPP4 304/4885 |
| US-20240140922-A1 | FUSED HETEROBICYCLIC ANTIVIRAL AGENTS | HAVCR2, HDGF, SLC10A1 | EPHX1 2238/4885ALDH1A1 3377/4885DPP4 316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.